Multidrug-resistant tuberculosis (MDR-TB) is a severe and feared problem, that is difficult to control and has shown a tendency to increase worldwide. Objective: To analyze the risk factors for acquired MDR-TB.Casuistic and methods: A retrospective population-based case-control study was conducted. A bacillus was considered multidrug-resistant whenever it was resistant at least to rifampin (RFP) + isoniazid (INH), and a case was considered as sensitive tuberculosis (TB) if it had undergone the first treatment during a similar period as the first treatment of an MDR-TB case, but was cured at the time of the interview. Case selection was made based on the list of Sensitivit
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance ...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
This case control study was conducted in selected centers of Dhaka City from March to July 2008 to d...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
Objective: The objective of our study was to determine the frequency of risk factors for MDR TB in v...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance ...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
This case control study was conducted in selected centers of Dhaka City from March to July 2008 to d...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
Objective: The objective of our study was to determine the frequency of risk factors for MDR TB in v...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...